Copyright Reports & Markets. All rights reserved.

Global Influenza Antiviral Drugs Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Influenza Antiviral Drugs Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Influenza Antiviral Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Oseltamivir
    • 1.4.3 Zanamivir
    • 1.4.4 Peramivir
    • 1.4.5 Adamantanes
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Influenza Antiviral Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Ambulatory Surgical Centers
    • 1.5.5 Pharmacies
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Influenza Antiviral Drugs Market Perspective (2015-2026)
  • 2.2 Influenza Antiviral Drugs Growth Trends by Regions
    • 2.2.1 Influenza Antiviral Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Influenza Antiviral Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Influenza Antiviral Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Influenza Antiviral Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Influenza Antiviral Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Influenza Antiviral Drugs Players by Market Size
    • 3.1.1 Global Top Influenza Antiviral Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Influenza Antiviral Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Influenza Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Influenza Antiviral Drugs Market Concentration Ratio
    • 3.2.1 Global Influenza Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Influenza Antiviral Drugs Revenue in 2019
  • 3.3 Influenza Antiviral Drugs Key Players Head office and Area Served
  • 3.4 Key Players Influenza Antiviral Drugs Product Solution and Service
  • 3.5 Date of Enter into Influenza Antiviral Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Influenza Antiviral Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Influenza Antiviral Drugs Forecasted Market Size by Type (2021-2026)

5 Influenza Antiviral Drugs Breakdown Data by Application (2015-2026)

  • 5.1 Global Influenza Antiviral Drugs Market Size by Application (2015-2020)
  • 5.2 Global Influenza Antiviral Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Influenza Antiviral Drugs Market Size (2015-2020)
  • 6.2 Influenza Antiviral Drugs Key Players in North America (2019-2020)
  • 6.3 North America Influenza Antiviral Drugs Market Size by Type (2015-2020)
  • 6.4 North America Influenza Antiviral Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Influenza Antiviral Drugs Market Size (2015-2020)
  • 7.2 Influenza Antiviral Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Influenza Antiviral Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Influenza Antiviral Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Influenza Antiviral Drugs Market Size (2015-2020)
  • 8.2 Influenza Antiviral Drugs Key Players in China (2019-2020)
  • 8.3 China Influenza Antiviral Drugs Market Size by Type (2015-2020)
  • 8.4 China Influenza Antiviral Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Influenza Antiviral Drugs Market Size (2015-2020)
  • 9.2 Influenza Antiviral Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Influenza Antiviral Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Influenza Antiviral Drugs Market Size by Application (2015-2020)

10 India

  • 10.1 India Influenza Antiviral Drugs Market Size (2015-2020)
  • 10.2 Influenza Antiviral Drugs Key Players in India (2019-2020)
  • 10.3 India Influenza Antiviral Drugs Market Size by Type (2015-2020)
  • 10.4 India Influenza Antiviral Drugs Market Size by Application (2015-2020)

11 Mid East & Africa

  • 11.1 Mid East & Africa Influenza Antiviral Drugs Market Size (2015-2020)
  • 11.2 Influenza Antiviral Drugs Key Players in Mid East & Africa (2019-2020)
  • 11.3 Mid East & Africa Influenza Antiviral Drugs Market Size by Type (2015-2020)
  • 11.4 Mid East & Africa Influenza Antiviral Drugs Market Size by Application (2015-2020)

12 Key Players Profiles

  • 12.1 GSK
    • 12.1.1 GSK Company Details
    • 12.1.2 GSK Business Overview and Its Total Revenue
    • 12.1.3 GSK Influenza Antiviral Drugs Introduction
    • 12.1.4 GSK Revenue in Influenza Antiviral Drugs Business (2015-2020))
    • 12.1.5 GSK Recent Development
  • 12.2 Boehringer Ingelheim
    • 12.2.1 Boehringer Ingelheim Company Details
    • 12.2.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 12.2.3 Boehringer Ingelheim Influenza Antiviral Drugs Introduction
    • 12.2.4 Boehringer Ingelheim Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.2.5 Boehringer Ingelheim Recent Development
  • 12.3 Merck
    • 12.3.1 Merck Company Details
    • 12.3.2 Merck Business Overview and Its Total Revenue
    • 12.3.3 Merck Influenza Antiviral Drugs Introduction
    • 12.3.4 Merck Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.3.5 Merck Recent Development
  • 12.4 Novartis
    • 12.4.1 Novartis Company Details
    • 12.4.2 Novartis Business Overview and Its Total Revenue
    • 12.4.3 Novartis Influenza Antiviral Drugs Introduction
    • 12.4.4 Novartis Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.4.5 Novartis Recent Development
  • 12.5 Beximco Pharmaceuticals
    • 12.5.1 Beximco Pharmaceuticals Company Details
    • 12.5.2 Beximco Pharmaceuticals Business Overview and Its Total Revenue
    • 12.5.3 Beximco Pharmaceuticals Influenza Antiviral Drugs Introduction
    • 12.5.4 Beximco Pharmaceuticals Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.5.5 Beximco Pharmaceuticals Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Company Details
    • 12.6.2 Pfizer Business Overview and Its Total Revenue
    • 12.6.3 Pfizer Influenza Antiviral Drugs Introduction
    • 12.6.4 Pfizer Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.6.5 Pfizer Recent Development
  • 12.7 Roche
    • 12.7.1 Roche Company Details
    • 12.7.2 Roche Business Overview and Its Total Revenue
    • 12.7.3 Roche Influenza Antiviral Drugs Introduction
    • 12.7.4 Roche Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.7.5 Roche Recent Development
  • 12.8 Johnson & Johnson
    • 12.8.1 Johnson & Johnson Company Details
    • 12.8.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 12.8.3 Johnson & Johnson Influenza Antiviral Drugs Introduction
    • 12.8.4 Johnson & Johnson Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.8.5 Johnson & Johnson Recent Development
  • 12.9 Sanofi
    • 12.9.1 Sanofi Company Details
    • 12.9.2 Sanofi Business Overview and Its Total Revenue
    • 12.9.3 Sanofi Influenza Antiviral Drugs Introduction
    • 12.9.4 Sanofi Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.9.5 Sanofi Recent Development
  • 12.10 Cipla Limited
    • 12.10.1 Cipla Limited Company Details
    • 12.10.2 Cipla Limited Business Overview and Its Total Revenue
    • 12.10.3 Cipla Limited Influenza Antiviral Drugs Introduction
    • 12.10.4 Cipla Limited Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 12.10.5 Cipla Limited Recent Development
  • 12.11 Natco Pharma
    • 10.11.1 Natco Pharma Company Details
    • 10.11.2 Natco Pharma Business Overview and Its Total Revenue
    • 10.11.3 Natco Pharma Influenza Antiviral Drugs Introduction
    • 10.11.4 Natco Pharma Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 10.11.5 Natco Pharma Recent Development
  • 12.12 Seqirus
    • 10.12.1 Seqirus Company Details
    • 10.12.2 Seqirus Business Overview and Its Total Revenue
    • 10.12.3 Seqirus Influenza Antiviral Drugs Introduction
    • 10.12.4 Seqirus Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 10.12.5 Seqirus Recent Development
  • 12.13 Adamas Pharmaceuticals, Inc.
    • 10.13.1 Adamas Pharmaceuticals, Inc. Company Details
    • 10.13.2 Adamas Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 10.13.3 Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Introduction
    • 10.13.4 Adamas Pharmaceuticals, Inc. Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 10.13.5 Adamas Pharmaceuticals, Inc. Recent Development
  • 12.14 Teva Pharmaceuticals
    • 10.14.1 Teva Pharmaceuticals Company Details
    • 10.14.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
    • 10.14.3 Teva Pharmaceuticals Influenza Antiviral Drugs Introduction
    • 10.14.4 Teva Pharmaceuticals Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 10.14.5 Teva Pharmaceuticals Recent Development
  • 12.15 Daiichi Sankyo Company
    • 10.15.1 Daiichi Sankyo Company Company Details
    • 10.15.2 Daiichi Sankyo Company Business Overview and Its Total Revenue
    • 10.15.3 Daiichi Sankyo Company Influenza Antiviral Drugs Introduction
    • 10.15.4 Daiichi Sankyo Company Revenue in Influenza Antiviral Drugs Business (2015-2020)
    • 10.15.5 Daiichi Sankyo Company Recent Development

13 Analyst's Viewpoints/Conclusions

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Disclaimer

    This report focuses on the global Influenza Antiviral Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Influenza Antiviral Drugs development in North America, Europe, China, Japan, India and Mid East & Africa.

    The key players covered in this study
    GSK
    Boehringer Ingelheim
    Merck
    Novartis
    Beximco Pharmaceuticals
    Pfizer
    Roche
    Johnson & Johnson
    Sanofi
    Cipla Limited
    Natco Pharma
    Seqirus
    Adamas Pharmaceuticals, Inc.
    Teva Pharmaceuticals
    Daiichi Sankyo Company

    Market segment by Type, the product can be split into
    Oseltamivir
    Zanamivir
    Peramivir
    Adamantanes
    Others
    Market segment by Application, split into
    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Pharmacies
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    India
    Mid East & Africa

    The study objectives of this report are:
    To analyze global Influenza Antiviral Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Influenza Antiviral Drugs development in North America, Europe, China, Japan, India and Mid East & Africa.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Influenza Antiviral Drugs are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now